DHR Danaher Corporation

Price (delayed)

$233.98

Market cap

$166.21B

P/E Ratio

46.52

Dividend/share

$0.71

EPS

$5.03

Enterprise value

$182.35B

Sector: Healthcare
Industry: Diagnostics & Research
Danaher Corp. operates as a medical company, which designs, manufactures, and markets professional, medical, industrial and commercial products and services. It operates through the following segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines. The Diagnostics segment comprises of analytical instruments, reagents, consumables, software, and services that hospitals, physician's offices, reference laboratories, and other critical care settings use to diagnose disease and make treatment decisions. The Environmental & Applied Solution segment offers products and services that help protect important resources and keep global food and water supplies safe. The company was founded by Steven M. Rales and Mitchell P. Rales in 1969 and is headquartered in Washington, DC.

Highlights

The net income has increased by 48% year-on-year and by 6% since the previous quarter
DHR's EPS is up by 48% year-on-year and by 6% since the previous quarter
The debt is up by 24% year-on-year but it has declined by 2.5% since the previous quarter
The price to earnings (P/E) is 60% more than the 5-year quarterly average of 29.0 and 26% more than the last 4 quarters average of 36.9
The quick ratio has declined by 49% year-on-year and by 4.4% since the previous quarter

Key stats

What are the main financial stats of DHR
Market
Shares outstanding
710.38M
Market cap
$166.21B
Enterprise value
$182.35B
Valuations
Price to earnings (P/E)
46.52
Price to book (P/B)
4.37
Price to sales (P/S)
9.06
EV/EBIT
39.46
EV/EBITDA
29.94
EV/Sales
9.93
Earnings
Revenue
$18.36B
EBIT
$4.62B
EBITDA
$6.09B
Free cash flow
$4.51B
Per share
EPS
$5.03
Free cash flow per share
$6.34
Book value per share
$53.51
Revenue per share
$25.83
TBVPS
$24.99
Balance sheet
Total assets
$72.89B
Total liabilities
$34.92B
Debt
$21.83B
Equity
$37.96B
Working capital
$6.5B
Liquidity
Debt to equity
0.57
Current ratio
2.08
Quick ratio
1.52
Net debt/EBITDA
2.65
Margins
EBITDA margin
33.2%
Gross margin
55%
Net margin
20%
Operating margin
18.8%
Efficiency
Return on assets
5.2%
Return on equity
10.5%
Return on invested capital
16.4%
Return on capital employed
6.9%
Return on sales
25.2%
Dividend
Dividend yield
0.3%
DPS
$0.71
Payout ratio
14.1%

DHR stock price

How has the Danaher stock price performed over time

Financial performance

How have Danaher's revenue and profit performed over time
Revenue
$18.36B
Gross profit
$10.1B
Operating income
$3.46B
Net income
$3.68B
Gross margin
55%
Net margin
20%
The net income has increased by 48% year-on-year and by 6% since the previous quarter
The net margin is up by 26% year-on-year but it has declined by 2.9% since the previous quarter
Danaher's operating income has increased by 18% YoY and by 10% from the previous quarter
Danaher's revenue has increased by 18% YoY and by 9% from the previous quarter

Growth

What is Danaher's growth rate over time

Valuation

What is Danaher stock price valuation
P/E
46.52
P/B
4.37
P/S
9.06
EV/EBIT
39.46
EV/EBITDA
29.94
EV/Sales
9.93
The price to earnings (P/E) is 60% more than the 5-year quarterly average of 29.0 and 26% more than the last 4 quarters average of 36.9
DHR's EPS is up by 48% year-on-year and by 6% since the previous quarter
The P/B is 56% more than the 5-year quarterly average of 2.8 and 25% more than the last 4 quarters average of 3.5
The equity has grown by 17% YoY and by 4.7% from the previous quarter
DHR's P/S is 85% above its 5-year quarterly average of 4.9 and 31% above its last 4 quarters average of 6.9
Danaher's revenue has increased by 18% YoY and by 9% from the previous quarter

Efficiency

How efficient is Danaher business performance
Danaher's ROE has increased by 35% YoY
DHR's return on sales is up by 17% year-on-year but it is down by 2.7% since the previous quarter
DHR's ROA is up by 16% year-on-year
The return on invested capital has declined by 12% year-on-year

Dividends

What is DHR's dividend history
DPS
$0.71
Dividend yield
0.3%
Payout ratio
14.1%
Recent dividends

Financial health

How did Danaher financials performed over time
The total assets is 109% greater than the total liabilities
The quick ratio has declined by 49% year-on-year and by 4.4% since the previous quarter
The current ratio has declined by 39% year-on-year and by 5% since the previous quarter
The debt is 43% smaller than the equity
The debt is up by 24% year-on-year but it has declined by 2.5% since the previous quarter
The equity has grown by 17% YoY and by 4.7% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.